Hepatitis C and diabetes: the inevitable coincidence?

Area of Science:

• Hepatology
• Endocrinology
• Virology

Background:

• Type 2 diabetes (T2D) and Hepatitis C Virus (HCV) infection are globally prevalent conditions.
• Emerging evidence suggests a significant relationship between HCV infection and T2D, with implications for liver disease progression.

Purpose of the Study:

• To explore the intricate relationship between HCV infection and the development of T2D and insulin resistance (IR).
• To review the impact of HCV-induced IR on liver fibrosis, treatment response, and patient outcomes.
• To identify areas for future research regarding metabolic strategies and cardiovascular risk in HCV patients.

Main Methods:

• Literature review and meta-analysis of existing studies on HCV and T2D prevalence.
• Analysis of clinical data linking HCV infection, IR, fibrosis, and treatment outcomes.
• Synthesis of evidence regarding the effects of antiviral treatments on IR and T2D in HCV patients.

Main Results:

• HCV infection is associated with an increased risk of T2D, with studies reporting a 1.8-fold excess risk compared to HBV-positive patients.
• Insulin resistance is a common finding in HCV infection, closely linked to liver fibrosis progression.
• HCV-positive patients with T2D face heightened risks of hepatic encephalopathy and hepatocellular carcinoma (HCC), especially those with cirrhosis.

Conclusions:

• HCV infection directly contributes to insulin resistance, influencing T2D development and progression.
• The interplay between HCV, IR, and liver disease necessitates further investigation into therapeutic strategies.
• Understanding these associations is crucial for improving patient prognosis and managing comorbidities like T2D in chronic hepatitis C.